Stay Alert for New GLP-1 Agonists and Flozins During Transitions of Care

February 2018

Patients will report taking new diabetes meds during admission histories as more GLP-1 agonists and SGLT2 inhibitors hit the market...

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Med Safety Limit the Use of Injectable Promethazine in Your Hospital
Kidney Disease Help Ensure the Safe Use of Secondary Hyperparathyroid Meds
Anesthesia Be Ready to Expedite Treatment for Malignant Hyperthermia
Critical Care Use Best Practices for Your Targeted Temperature Management Protocols
Interactions Contact Your Lab if Patients Report High Biotin Use
New Drugs Stay Alert for New GLP-1 Agonists and Flozins During Transitions of Care
New Drugs Help Avoid Errors With the New HIV Drug, Juluca
Monitoring Help Answer Questions About Using Continuous Glucose Monitors in the Hospital
Cardiology Help Optimize Medication Management for Stable Coronary Artery Disease
Travel Medicine Be Prepared to Treat Patients With Altitude Illness
New Drugs Stay Alert for New GLP-1 Agonists and Flozins During Transitions of Care
New Drugs Help Avoid Errors With the New HIV Drug, Juluca